Cancer of the thyroid.
These relatively infrequent tumors intrigue both clinican and researcher. Each histologic type posesses its own distinctive natural history, controversy surrounds therapeutic programs, and prognosis is influenced by multiple factors, varying from a fatal outcome within a few months to a nearly normal life expectancy. Since fatalities do occur in patients with well differentiated cancers, a more aggressive approach to all thyroid nodules would improve current survival rates.
D000230:Adenocarcinoma / Q000145:classification; D000367:Age Factors; D000368:Aged; D002277:Carcinoma / Q000145:classification / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007457:Iodine Radioisotopes / Q000009:adverse effects; D008223:Lymphoma / Q000145:classification; D008875:Middle Aged; D011182:Postoperative Care; D011379:Prognosis; D012509:Sarcoma / Q000145:classification; D013963:Thyroid Hormones / Q000627:therapeutic use; D013964:Thyroid Neoplasms / Q000145:classification / Q000188:drug therapy / Q000209:etiology / Q000532:radiotherapy / Q000601:surgery; D013972:Thyrotropin / Q000378:metabolism
D007457:Iodine Radioisotopes; D013963:Thyroid Hormones; D013972:Thyrotropin